April 19 -- Tianjin Ringpu Bio-technology (300119.SZ) filed its net profit attributable to shareholders grew 14.5 percent year-on-year to 22.41 million yuan in the first quarter on revenue growth of 56.61 percent to 130.34 million yuan, reports China Securities Journal.

Its veterinary biological products, veterinary agents, and veterinary pharmaceutical ingredients respectively contributed revenue of 74.64 million yuan, 25.25 million yuan, and 35.58 million yuan in the first quarter.